Table 1.
Comparison of the present case with previously reported indigo naturalis-associated intussusception cases
| Age/sex | IN/CurQD dose | Time to onset (wk) | Location | Management | IN/CurQD after event |
| Present case, 42/F | CurQD 4 g/d | 5 | Ascending colon | Right hemicolectomy | Discontinued |
| 52/M | Unknown | 7 | Ascending colon | Conservative | Discontinued |
| 35/M | Unknown | Unknown | Cecum | Conservative | Continued → recurrence |
| 37/F | 2 g | 8 | Cecum | Endoscopic | Discontinued |
| 26/M | Unknown | 3 | Cecum, ascending colon | Endoscopic | Unknown |
| 35/M | 1–2 g | 4 | Ascending colon | Endoscopic | Discontinued |
| 40/M | Unknown | 5 | Cecum | Endoscopic | Continued |
| 45/M | 0.5 g | 5 | Cecum, ascending colon | Surgery | Discontinued |
| 32/M | 0.5 g | 3 | Ascending colon | Surgery | Discontinued |
| 43/F | 1 g | 8 | Cecum | Surgery | Discontinued |
| 39/F | 2 g | 3 | Cecum, ascending colon | Surgery | Continued |
Data for previously reported cases adapted from Naganuma et al.6
CurQD, curcumin QingDai; IN, indigo naturalis.